Lataa...
Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures
In early stage non-small cell lung cancer (NSCLC) large randomized trials have demonstrated that in patients with radically resected disease adjuvant chemotherapy improves 5-year survival rates. However, a customization of systemic treatment is needed to avoid treatments in patients cured by surgery...
Tallennettuna:
| Julkaisussa: | Transl Lung Cancer Res |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Pioneer Bioscience Publishing Company
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367732/ https://ncbi.nlm.nih.gov/pubmed/25806256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2013.10.05 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|